Natco Launch New Products Oncology


Posted August 6, 2018 by dipun2007

Getinat,Erlonat products are launched in Market,Both the medicines very effective for patients.

 
Geftinat 250 mg Tablet is an anticancer medicine which is used in the treatment of cancer of the lungs. It should only be used under the supervision of a qualified physician. This medicine is not recommended for use in patients with lung and liver diseases.
Erlonat 150Mg Tablet is prescribed to patients suffering from metastatic lung cancer, or cancer of the lung which is at a very advanced stage. It is also used in the treatment of some kinds of pancreatic cancers, along with a combination of other drugs.

Erlonat 150Mg Tablet is known to be a tyrosine kinase inhibitor, and functions by preventing growth of cancer cells, and destroying them in the process.

Erlonat 150Mg Tablet is generally not prescribed to patients who are hypersensitive to any substance that is present in it, or are undergoing chemotherapy that is platinum based. Patients who are using a proton pump inhibitor should not take Erlonat 150Mg Tablet either.

The medicine should be taken orally at least an hour before a meal. You can gulp it down with the help of some water. In case of a missed dose, get in touch with your health professional and seek advice.

It is best to be aware of certain side effects that occur because of Erlonat 150Mg Tablet consumption. Some minor side effects are dryness of the eyes, belching, loss of weight, heart burn, pain in the bones and joints, gas, pain in the stomach and appearance of pimples.

Some major side effects include rashes, tightness of the chest, pain in the lower back regio
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Santosh Kumar Prusty
Website http://www.1mg.com
Phone 9715341478
Business Address D-24,Jawahar park,Devli Road,
Khanpur,New Delhi-110062
Country India
Categories Accounting
Tags erlonat 150 mg tab , geftinat 250 mg tab
Last Updated August 6, 2018